期刊
EUROPEAN JOURNAL OF HEART FAILURE
卷 24, 期 7, 页码 1319-1322出版社
WILEY
DOI: 10.1002/ejhf.2590
关键词
SARS-CoV-2 vaccine; Giant cell myocarditis; Cardiac magnetic resonance imaging; Endomyocardial biopsy
资金
- Projekt DEAL
This case report describes a young man who was admitted to the Department of Cardiology and Angiology at Hannover Medical School with symptoms of shortness of breath and elevated troponin. After being diagnosed with giant cell myocarditis and having received the first dose of BioNTech's mRNA vaccine, the patient was treated with immunosuppressive therapy. The article discusses this rare etiology of myocarditis following mRNA vaccination and the treatment strategy employed in this particular case according to current recommendations.
Herein we report the case of a young man, admitted to the Department of Cardiology and Angiology at Hannover Medical School with shortness of breath and elevated troponin. Few weeks earlier the patient received the first dose of BioNTech's mRNA vaccine (Comirnaty, BNT162b2). After diagnostic work-up revealed giant cell myocarditis, the patient received immunosuppressive therapy. In the present context of myocarditis after mRNA vaccination we discuss this rare aetiology and the patient's treatment strategy in the light of current recommendations.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据